Ascend dabigatran capsules recalled for failed impurity specifications
Ascend Laboratories is recalling dabigatran etexilate capsules, 110 mg, after an out-of-specification result in 12-month long-term stability testing for Impurity II, Impurity III and total impurities. This means the product failed its impurity specifications. No injuries have been reported.
From the FDA notice · Read the official notice ↗ · All Ascend Laboratories recalls
What to do
- Talk to your pharmacist or prescriber before stopping this medicine.
- Check whether your carton is a 60-count carton with NDC 0904-7254-68 and lot 25141707, expiration 4/30/2027.
- The notice doesn't say how to get a refund or replacement; contact Ascend Laboratories or the pharmacy where you bought it.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Dabigatran etexilate Capsules, 110 mg, 60-count carton (6x10), Rx Only, Manufactured by: Alkem Laboratories, Mumbai, INDIA, Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, NDC 0904-7254-68.
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
This recall covers 2 products — see all of them.
Details
- Units affected
- 1,753 cartons
- Illnesses reported
- None reported
- Manufactured in
- 135 Us Highway 202 206 Ste 15, N/A, Bedminster, NJ, United States
- Classification
- Class III
- Recall number
- D-0735-2026
In the FDA's words
- Description
- Dabigatran etexilate Capsules, 110 mg, 60-count carton (6x10), Rx Only, Manufactured by: Alkem Laboratories, Mumbai, INDIA, Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, NDC 0904-7254-68. Failed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II, Impurity III and Total impurity testing for 12 Month Long-Term Stability. Lot: 25141707, Exp 4/30/2027. Distribution: USA Nationwide Affected quantity: 1,753 cartons
- Hazard
- Failed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II, Impurity III and Total impurity testing for 12 Month Long-Term Stability.
2 products in this recall
The agency lists each product separately. Check every one you might have.
- Dabigatran etexilate Capsules, 110 mg, 60-count carton (6x10), Rx Only, Manufactured by: Alkem Laboratories, Mumbai, INDIA, Distributed by: Major Pharmaceuti… (this page)D-0735-2026 · 1,753 cartons
- Dabigatran etexilate Capsules, 150 mg, 20-count carton (2x10), Rx only, Manufactured by: Alkem Laboratories, Mumbai, INDIA, Distributed by: Major Pharmaceuti…D-0736-2026 · 2,717 cartons
More from Ascend Laboratories
See all- Ascend amlodipine/olmesartan tablets recalled for failed dissolution
ModerateFDAOct 16, 2026